Topic Highlight
Copyright ©The Author(s) 2016.
World J Hepatol. Jan 18, 2016; 8(2): 92-106
Published online Jan 18, 2016. doi: 10.4254/wjh.v8.i2.92
Figure 1
Figure 1 Hepatitis C virus replicative cycle and main targets for direct acting antiviral agents. Modified from Manns and Cornberg. Lancet Infectious Diseases 2013. PIs: Protease inhibitors; NPIs: Nucleoside polymerase inhibitors; NNPIs: Non-nucleoside polymerase inhibitors.